Appointment | Mike Shaw as CBO

June 2026

Knowing your enemy requires more than great science. It also requires the right people. We are therefore delighted to welcome Mike Shaw as our Chief Business Officer.

Mike brings over twenty years of experience spanning the biotech industry and academia, with a proven track record in business development, drug discovery, innovation, and antibody development. He has held senior roles at Kiadis, Sanofi, Genmab, and Leyden Labs, and most recently served as Vice President BD & Innovation at Avidicure.

With Mike joining the team, we take an important step in turning the molecular insights from circulating tumor cells into impactful cancer therapies.

We are very much looking forward to what we will build together!